News

News
Other news

ONL Therapeutics Closes $46.9 Million in Series B Financing to Advance ONL1204 into Three Retinal Disease Indications

Read full story
Other news

XWPharma Names Michael M. Morrissey, PhD to Board of Directors

Read full story
Other news

Big Data Institute announces collaboration with Janssen to advance understanding of human genetic signatures

Read full story
Other news

Cue’s Molecular, Point-of-Care COVID-19 Tests Deployed to Five States in HHS and DOD Pilot Program

Read full story
Other news

DERMALA Announces $6.73 Million Series A Financing to Expand and Scale Company’s Personalized Microbiome-Based Solutions for Acne and Other Skin Conditions

Read full story
Other news

Cue Receives $481 Million Award by DOD and HHS to Expand Domestic Production Capacity and Provide 6 Million Molecular, Point-of-Care COVID-19 Tests

Read full story
Other news

Datavant Raises $40 Million in Series B Financing to Expand Open Health Data Ecosystem

Read full story
Other news

Dr. Sadasivan Vidyasagar, Associate Professor at University of Florida, and entrinsic bioscience CEO Stephen Gatto, Receive University of Florida's 'Invention of the Year 2020' Award

Read full story
Other news

V-Wave Completes Financing of Up to $98M from Syndicate of Leading Global Healthcare Investors

Read full story
Other news

XWPharma Announces $40 Million Financing and Appoints Leonard Blum as Chief Executive Officer

Read full story
Other news

Infinite Looks Announces Investment from Johnson & Johnson Innovation - JJDC, Inc. to Accelerate Sunday II Sunday, the Ethnic Hair Care Line

Read full story
JNJ Press releases

Johnson & Johnson Innovation and Janssen Announce the Awardees of the World Without Disease Call-for-Proposal

Read full story
Other news

Aetion adds strategic investment from Johnson & Johnson Innovation - JJDC, Inc., EDBI, Greenspring Associates to expand RWE offerings

Read full story
Other news

Fate Therapeutics Announces Worldwide Collaboration with Janssen for Novel iPSC-derived Cell-based Cancer Immunotherapies

Read full story